Cor Vasa 2016, 58(6):e584-e590 | DOI: 10.1016/j.crvasa.2015.11.001
The impact of diabetes on electrocardiographic ST resolution and clinical outcome of acute ST elevation myocardial infarction following fibrinolytic therapy
- a Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- b Reproductive Health Research Center, Urmia University of Medical Sciences, Urmia, Iran
- c University at Buffalo, United States
Objective: To investigate the association of diabetes with ST segment resolution and clinical outcomes after fibrinolysis in patients with first ST elevation myocardial infarction (STEMI).
Methods and results: Clinical information from 275 consecutive patients with first STEMI, who received streptokinase within six hours of chest pain initiation, was collected prospectively. ST resolution ≥ 50%, ninety minutes after fibrinolysis was considered as a sign of successful reperfusion. Association of diabetes with the risk of reperfusion failure, development of heart failure and in-hospital mortality was determined before and after controlling for other coronary risk factors.
ST resolution ≥ 50% was present in 45.1% of non-diabetics and 48.7% of diabetics (p = 0.1). Heart failure and in-hospital mortality were more common in diabetics (25.7% vs. 14.8%, p = 0.03 and 17.8% vs. 8.4%, p = 0.03, respectively). Diabetics were more likely to have three-vessel disease in coronary angiography (23% vs. 8%, p < 0.001). After controlling for baseline characteristics, diabetes was not independently associated with reperfusion failure and major adverse cardiac events, including heart failure and in-hospital mortality.
Conclusions: ST resolution is not affected by the presence of diabetes. Although diabetics have higher prevalence of heart failure and in-hospital mortality after treatment of STEMI with streptokinase, their poor outcome is most likely due to higher burden of simultaneous coronary risk factors.
Keywords: Diabetes mellitus; Electrocardiography; Myocardial infarction; Thrombolysis
Received: September 3, 2015; Revised: October 30, 2015; Accepted: November 1, 2015; Published: December 1, 2016 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- D. Mozaffarian, E.J. Benjamin, A.S. Go, et al., Heart Disease and Stroke Statistics-2015 update: a report from the American Heart Association, Circulation 129 (2014) e28-e292.
Go to PubMed...
- S. Sattur, B. Sarwar, T.J. Sacchi, S.J. Brener, Correlation between markers of reperfusion and mortality in ST-elevation myocardial infarction: a systematic review, Journal of Invasive Cardiology 26 (2014) 587-595.
Go to PubMed...
- S. Rao, B.S. Patil, Predictors of failed thrombolysis in acute myocardial infarction, International Journal of Biomedical Research 3 (2012) 239-244.
Go to original source...
- J.R. Timmer, J.P. Ottervanger, M.J. de Boer, et al., Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial, Archives of Internal Medicine 167 (2007) 1353-1359.
Go to original source...
Go to PubMed...
- N. Danchin, E. Puymirat, P.G. Steg, et al., Five-year survival in patients with ST-segment elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 cohort, Circulation (2014), http://dx.doi.org/10.1161/CIRCULATIONAHA.113.005874.
Go to original source...
Go to PubMed...
- P.W. Armstrong, D. Collen, E. Antman, Fibrinolysis for acute myocardial infarction: the future is here and now, Circulation 107 (2003) 2533-2537.
Go to original source...
Go to PubMed...
- L. Bhatia, G.J. Clesham, D.R. Turner, Clinical implications of ST-segment non-resolution after thrombolysis for myocardial infarction, Journal of the Royal Society of Medicine 97 (2004) 566-570.
Go to original source...
Go to PubMed...
- J.A. de Lemos, E. Braunwald, ST segment resolution as a tool for assessing the efficacy of reperfusion therapy, Journal of the American College of Cardiology 38 (2001) 1283-1294.
Go to original source...
Go to PubMed...
- R. Schroder, Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction, Circulation 110 (2004) e506-e510.
Go to original source...
Go to PubMed...
- L.F. Hsu, K.H. Mak, K.W. Lau, et al., Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis, Heart (British Cardiac Society) 88 (2002) 260-265.
Go to original source...
Go to PubMed...
- M. Chiha, M. Njeim, E.G. Chedrawy, Diabetes and coronary heart disease: a risk factor for the global epidemic, International Journal of Hypertension 2012 (2012) 697240.
Go to original source...
Go to PubMed...
- M. Masoomi, S. Samadi, M. Sheikhvatan, Thrombolytic effect of streptokinase infusion assessed by ST-segment resolution between diabetic and non-diabetic myocardial infarction patients, Cardiology Journal 19 (2012) 168-173.
Go to original source...
Go to PubMed...
- B.G. Angeja, J. de Lemos, S.A. Murphy, et al., Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy, American Heart Journal 144 (2002) 649-656.
Go to original source...
Go to PubMed...
- M.N. Zairis, A.G. Lyras, S.S. Makrygiannis, et al., Type 2 diabetes and intravenous thrombolysis outcome in the setting of ST elevation myocardial infarction, Diabetes Care 27 (2004) 967-971.
Go to original source...
- M.A.R. Chowdhury, A.K.M.M. Hossain, S.R. Dey, et al., A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients, Bangladesh Journal of Pharmacology 3 (2008) 1-7.
Go to original source...
- S.R. Park, Y.R. Kang, M.K. Seo, et al., Clinical predictors of incomplete ST-segment resolution in the patients with acute ST segment elevation myocardial infarction, Korean Circulation Journal 39 (2009) 310-316.
Go to original source...
Go to PubMed...
- S. Dobrzycki, M. Kozuch, K. Kaminski, et al., High cholesterol in patients with ECG signs of no-reflow after myocardial infarction, Roczniki Akademii Medycznej w Bialymstoku (1995) 48 (2003) 118-122.
Go to PubMed...
- K.H. Mak, D.J. Moliterno, C.B. Granger, et al., Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries, Journal of the American College of Cardiology 30 (1997) 171-179.
Go to original source...
Go to PubMed...
- M. Tomasevic, T. Kostic, S. Apostolovic, et al., Comparative effect of streptokinase and alteplase on electrocardiogram and angiogram signs of myocardial reperfusion in ST segment elevation acute myocardial infarction, Srpski arhiv za celokupno lekarstvo 136 (2008) 481-487.
Go to original source...
Go to PubMed...
- H.L. Kim, S.H. Kang, C.H. Yoon, et al., Differential prognostic impacts of diabetes over time course after acute myocardial infarction, Journal of Korean Medical Science 28 (2013) 1749-1755.
Go to original source...
Go to PubMed...
- G. de Gevigney, D. Cao, E. Macfadden, et al., Do differences in baseline characteristics or in management account for the poorer in-hospital and subsequent outcome after myocardial infarction in diabetics? Data from a large unselected cohort, Acta Cardiologica 57 (2002) 187-196.
Go to original source...
Go to PubMed...
- J.R. Timmer, J.P. Ottervanger, K. Thomas, et al., Long-term, cause-specific mortality after myocardial infarction in diabetes, European Heart Journal 25 (2004) 926-931.
Go to original source...
Go to PubMed...
- P. Grant, Diabetes mellitus as a prothrombotic condition, Journal of Internal Medicine 262 (2007) 157-172.
Go to original source...
Go to PubMed...
- A. Undas, I. Wiek, E. Stêpień, et al., Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome, Diabetes Care 31 (2008) 1590-1595.
Go to original source...
Go to PubMed...
- M.I. Worthley, F.M. Shrive, T.J. Anderson, M. Traboulsi, Prognostic implication of hyperglycemia in myocardial infarction and primary angioplasty, American Journal of Medicine 120 (2007) 643.e1-7.
Go to original source...
Go to PubMed...
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group, Lancet 343 (1994) 311-322.
- C. Kocas, O. Abaci, G.S. Halil, et al., Admission hyperglycemia is associated with failed reperfusion following fibrinolytic therapy in patients with STEMI: results of a retrospective study, American Journal of Cardiovascular Drugs 15 (2015) 35-42.
Go to original source...
Go to PubMed...
- C.F. Lundergan, J.S. Reiner, W.F. McCarthy, et al., Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries, Journal of the American College of Cardiology 32 (1998) 641-647.
Go to original source...
Go to PubMed...
- S.L. Woodfield, C.F. Lundergan, J.S. Reiner, et al., Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience, Journal of the American College of Cardiology 28 (1996) 1661-1669.
Go to original source...
Go to PubMed...
- Y.Y. Lee, M.H. Tee, Y. Zurkurnai, et al., Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria, Singapore Medical Journal 49 (2008) 304-310.
- D.K. McGuire, H. Emanuelsson, C.B. Granger, et al., Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study, European Heart Journal 21 (2000) 1750-1758.
Go to original source...
Go to PubMed...
- M.O. Gore, M.J. Patel, M. Kosiborod, et al., Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction, Circulation Cardiovascular Quality and Outcomes 5 (2012) 791-797.
Go to original source...
Go to PubMed...
- H. Vihonen, I. Tierala, M. Kuisma, et al., Ultra-acute increase in blood glucose during prehospital phase is associated with worse short-term and long-term survival in ST-elevation myocardial infarction, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 22 (2014) 30.
Go to original source...
Go to PubMed...